{
  "docId": "019dd923-5fec-763b-95d0-6c2b37f81466",
  "docSlug": "bi-9523b367be63361f",
  "documentTitle": "3T Biosciences 27-slide pitch deck to raise $40M Series A",
  "authorId": "Pitchdecks",
  "authorName": "3T Biosciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.6,
  "pageNumber": 9,
  "pageCount": 27,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The diagram illustrates a process flow from patient cohort to target identification and candidate selection.",
  "elementsJson": [
    "headline_text",
    "action_title",
    "numbered_list",
    "process_diagram"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fec-763b-95d0-6c2b37f81466/9",
  "deckHref": "/decks/019dd923-5fec-763b-95d0-6c2b37f81466",
  "deckJsonHref": "/decks/019dd923-5fec-763b-95d0-6c2b37f81466.json",
  "deckAnchorHref": "/decks/019dd923-5fec-763b-95d0-6c2b37f81466#slide-9",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Science meets AI: TRACE™, a yeast display platform combined with active machine learning, identifies novel targets and T cell receptors (TCRs)",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-c0aa-76ce-98c0-8580ddff8134",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.58,
        "x": 0.38,
        "y": 0.41
      },
      "kind": "diagram",
      "text": "Process flow diagram showing patient cohort, TCRs, 3T-TRACE™ platform, and candidate selection.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fef62bd4-7df1-4e4f-b1ef-5a7cc79242c5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.35,
        "x": 0.04,
        "y": 0.43
      },
      "kind": "list",
      "text": "This innovative approach eliminates two major challenges in advancing TCR-based therapeutics: 1. Identifying Novel Therapeutic Targets 2. Ability to prospectively assess the specificity and cross-reactivity of T-cell receptor therapeutics",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1b214175-bd4f-4035-918e-f1fff677c67e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.92,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "paragraph",
      "text": "Science meets AI: TRACE™, a yeast display platform combined with active machine learning, identifies novel targets and T cell receptors (TCRs)",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2f3ba884-93e0-4073-931e-1403401f052c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.75,
        "x": 0.04,
        "y": 0.07
      },
      "kind": "title",
      "text": "3T-TRACE™ Technology Enables the Discovery of Novel Immunotherapies",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6dc4c654-9ea0-46fb-8c3a-f0aaf916bcf9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Process flow",
      "slug": "process-flow",
      "agent": null,
      "layer": "slide",
      "matchId": "b7764e7f-f323-48e9-9580-d82e3e32e0a8",
      "evidence": "diagram/process: Process flow diagram showing patient cohort, TCRs, 3T-TRACE™ platform, and candidate selection.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 14,
      "from": 9,
      "beatId": "c34a9755-7a6b-48d1-a15b-2dfcd73e13f3",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Slides 9-14 present 3T Biosciences' solution, including the 3T-TRACE technology and rapid lead discovery capabilities",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 14,
      "from": 9,
      "name": "Jobs To Be Done",
      "slug": "53-jobs-to-be-done",
      "bestFor": "Product innovation, market entry, competitive positioning",
      "matchId": "c615ad3c-1d3c-4c63-ad44-eb6f9a4c8d6d",
      "evidence": "The deck presents 3T Biosciences' platform and its capabilities in discovering novel immunotherapies",
      "position": 1,
      "objective": "Show how 3T Biosciences' platform enables the discovery of novel immunotherapies",
      "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
      "confidence": 0.6,
      "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}